E2F1, which was preferentially essential in pancreatic cancer cells, has been previously shown to regulate both pancreatic B-cell development and cancer growth by increasing the expression of PDK1 and PDK3 which results in increased aerobic glycolysis and growth in pancreatic cancers (41–43). Here, E2F1 is linked to pancreatic neoplasm.